<DOC>
	<DOCNO>NCT03043742</DOCNO>
	<brief_summary>Assess safety effectiveness stem cell application regard improvement regional myocardial function patient receive Trans-Myocardial Laser Revascularization ( TMR ) stem cell .</brief_summary>
	<brief_title>Stem Cell Heart Injections During Laser Revascularization Surgery Treatment Chronic Ischemic Heart Disease</brief_title>
	<detailed_description>Multiple case experience study publish review clinical experience Carbon Dioxide Trans-Myocardial Laser Revascularization ( TMR ) autologous bone marrow derive cell application . These experience demonstrate perfusion improvement , ejection fraction improvement improvement angina heart failure symptom . The investigator elect examine use CD133 positive ( CD133+ ) BM-derived stem cell pluripotent nature fact CD133 selection process inflammatory cell present bone marrow discard . CD133+ recently discover marker primitive bone marrow derive multipotent stem endothelial progenitor cell particular interest study direct therapeutic angiogenesis , cell show differentiate endothelial myogenic cell line . Multiple study utilized BM derive cell myocardial regeneration . Patients receive CD133+ cell show improved perfusion injection sit stem cell lead significant increase volume leave ventricular ejection fraction , regional wall motion infarct zone , reduction end systolic leave ventricular volume .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Presence least two vessel coronary artery disease amenable direct revascularization Area interest define part free leave ventricular vall reduce contractility Demonstration reduce perfusion area interest ( &gt; 30 % free wall ) Global ejection fraction 3045 % symptoms class &gt; _ II NYHA scale Significant refractory angina define symptom class &gt; _ III refractory maximal medical antiangina therapy Expected survival least two year Any condition prevents successful stem cell collection application , e.g . systemic infection , puncture stem cell collection impossible Any condition may adversely affect bone marrow malignancy prior irradiation pelvic bone Mitral valve insufficiency &gt; moderate grade History ventricular arrhythmia control medication and/or AICD Need additional heart surgery ( i.e . valve replacement ) Emergency salvage operation define within 48 hour diagnosis Evidence leave ventricular thrombus Previous heart surgery within last 6 month Increased Troponin T ( &gt; 3X ULN ) patient unstable angina time intervention History symptomatic carotid disease within last 3 month prior study intervention Ejection fraction &lt; 30 % End stage renal disease Untreatable cancer , current within precede 5 year Severe COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>